Correction: Continuing a cancer treatment despite tumor growth may be valuable: Sunitinib in renal cell carcinoma as example

Lignende værker

• Continuing a Cancer Treatment Despite Tumor Growth May Be Valuable: Sunitinib in Renal Cell Carcinoma as Example
  af: Burotto, Mauricio, et al.
  Udgivet: (2014)
• Sunitinib Does Not Accelerate Tumor Growth in Patients with Metastatic Renal Cell Carcinoma
  af: Krastan B. Blagoev, et al.
  Udgivet: (2013-02-01)
• Sunitinib Does Not Accelerate Tumor Growth in Patients with Metastatic Renal Cell Carcinoma
  af: Blagoev, Krastan B., et al.
  Udgivet: (2013)
• Sunitinib in the treatment of metastatic renal cell carcinoma
  af: Schmid, Thomas A., et al.
  Udgivet: (2016)
• Correction to: Feasibility, Safety, and Efficacy of an Alternative Schedule of Sunitinib for the Treatment of Patients with Metastatic Renal Cell Carcinoma: A Retrospective Study
  af: Buti, Sebastiano, et al.
  Udgivet: (2018)